Central Securities Corporation Declares Year-End Distribution
NEW YORK–(BUSINESS WIRE)–Central Securities Corporation (NYSE American: CET), a closed-end investment company, today declared a distribution of $1.65... Read more.
Leading Vancouver Wealth Management Firm Celebrates 50 Years of Excellence
VANCOUVER, British Columbia–(BUSINESS WIRE)–RGF Integrated Wealth Management is proud to announce the celebration of our 50th anniversary. Since our... Read more.
Ecority Will Catalyze a National Network of Credit Unions and State-Chartered Green Banks to Deploy Clean Energy Projects Through the EPA Greenhouse Gas Reduction Fund
SAN ANTONIO–(BUSINESS WIRE)–Ecority, a nonprofit coalition of credit unions and state-chartered green banks, has applied to the EPA-administered Greenhouse... Read more.
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
EL MONTE, Calif.–(BUSINESS WIRE)–Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established... Read more.
Keysight Completes the Acquisition of a Controlling Block of Shares of ESI Group and Confirms its Intent to Launch a Tender Offer for the Remaining Outstanding Shares
Completion of Keysight’s acquisition of a controlling block representing 50.6% of the share capital of ESI Group. Intent to file a public tender offer (“offre... Read more.
Agilysys Announces Mandatory Conversion Date for Series A Convertible Preferred Stock
ALPHARETTA, Ga.–(BUSINESS WIRE)–Agilysys, Inc. (Nasdaq: AGYS) announced today that it has delivered a notice of mandatory conversion to the holders of... Read more.
Hudson Therapeutics, Inc. Appoints Janice Marie McCourt as co-Chief Executive Officer and Board Member
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Hudson Therapeutics, Inc., a biotechnology company specializing in anti-inflammatory and immuno-oncology... Read more.
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments... Read more.
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments... Read more.
Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
LA JOLLA, Calif.–(BUSINESS WIRE)–$LBPH #Epilepsy—Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused... Read more.